Hospital News and Research

RSS

Study proposes a systematic engineering approach of optimizing protein-fortified food inks

As the global population continues to age and grow, the demand for protein-rich food is also expected to increase concurrently.

8 Aug 2022

Researchers create CAR T cells for cancer immunotherapy

In CAR T-cell immunotherapy, T cells taken from the patient’s own blood are modified to contain so-called chimeric antigen receptors (CAR), which provide the T cells the ability to target and eradicate tumor cells.

8 Aug 2022

Researchers propose a solution to delayed molecular diagnosis and therapy in childhood genetic diseases

Rady Children’s Institute for Genomic Medicine (RCIGM®) recently announced the publication in Nature Communications of research that describes and examines the efficiency of Genome-to-Treatment (GTRxTM), a computer-controlled, virtual disease management system that combines a quick Whole Genome Sequencing (rWGS®) diagnosis accomplished in 13.5 hours with a custom lab management information system and analysis pipeline.

28 Jul 2022

Research shows how protein deficiency creates motor disorders in flies

Scientists at the Universities of Bonn and Osnabrück have identified a protein that when defective in flies results in motor dysfunction.

26 Jul 2022

Study highlights retrotransposition in CRISPR gene therapy clinical trials

Worldwide clinical studies for gene therapy utilizing CRISPR/Cas9 gene editing are now underway for a number of disorders. A study from Boston Children’s Hospital that was released in Nature Communications on June 27th, 2022, alerts readers to a possible CRISPR editing risk that has not yet been identified.

8 Jul 2022

Probiotics do not enhance unhealthy vaginal health, recent study shows

Several factors, such as the type of bacteria that naturally colonize the reproductive tract, can influence pregnancy chances in IVF. “Good” bacteria in the form of probiotics are gaining popularity in the treatment of vaginal microbiota imbalances in women.

5 Jul 2022

Study deciphers the mechanisms of bacterial host cell adhesion

To create a new class of antibiotics, investigators from University Hospital Frankfurt and Goethe University Frankfurt have figured out how bacteria adhere to host cells.

4 Jul 2022

Research highlights the new genetic variations and pediatric NAFLD severity

A multidisciplinary group of researchers at the University of California San Diego School of Medicine have advanced investigations into the genetic causes of NAFLD in children.

1 Jul 2022

Research shows how new drugs may target genetic variations to slow Parkinson’s diseases

According to a new study presented at the 8th European Academy of Neurology (EAN) Congress, the duration of Parkinson’s disease may depend on particular gene mutations.

1 Jul 2022

Scientists discover proteins that may improve CAR-T cell therapy for solid tumor model

The potential of CAR T-cell therapy for the treatment of solid tumors was unlocked in a preclinical trial by researchers at St. Jude Children’s Research Hospital who discovered a molecular mechanism. The findings were released in the journal Nature.

27 Jun 2022

Novel inexpensive method to detect synthetic cannabinoids and banned pesticides quickly

To create innovative tests for a variety of chemicals, such as banned pesticides and dangerous, synthetic cannabinoids, scientists have changed proteins that are involved in plants’ natural reactions to stress.

27 Jun 2022

Researchers discover a way for detecting resistance-encoding genes in bacteria

Chalmers University of Technology researchers have devised a method for detecting certain bacterial genes that encode resistance using conventional microscopes, which are already used to diagnose TB in low-income countries.

27 Jun 2022

Researchers discover effective therapy for pediatric T-acute leukemia

The most frequent type of malignancy in kids is acute lymphoblastic leukemia (ALL).

27 Jun 2022

New computer model helps identify mutations that drive tumor growth

Cancer cells can have thousands of mutations in their DNA. However, only a handful of those actually drive the progression of cancer; the rest are just along for the ride.

22 Jun 2022

Researchers discover a new interferon-gamma receptor signaling pathway

The interferon-gamma receptor (IFNgR) signaling pathway has been identified to be crucial for the vulnerability of glioblastoma tumors to death by CAR T-cell immunotherapy, according to researchers at Massachusetts General Hospital (MGH).

10 Jun 2022

Research findings provide clues on the properties that might have made A. baumannii a successful pathogen

Over 670,000 people in Europe become ill each year as a result of pathogenic bacteria that are resistant to antibiotics, and 33,000 people die as a result of the diseases they cause. Pathogens that are resistant to multiple antibiotics at the same time are particularly dangerous.

6 Jun 2022

Researchers analyze functional microglia to empower retinal organ

Professor Zi-Bing Jin is in charge of this research (Beijing Institute of Ophthalmology, Beijing Tongren Eye Center, Beijing Tongren Hospital, and Capital Medical University). He has spent the last decade working on retinal organoids, which can accurately mimic retinal development.

3 Jun 2022

Damaged liver treated in perfusion machine for three days and then implanted into a cancer patient

The multidisciplinary Zurich research team Liver4Life has succeeded in doing something during a treatment attempt that had never been achieved in the history of medicine until now: it treated an originally damaged human liver in a machine for three days outside a body and then implanted the recovered organ into a cancer patient.

1 Jun 2022

Scientists discover a new left-handed Z-DNA technique to kill hard-to-treat tumors

An international collaboration of scientists has discovered a new technique to kill cancers that are difficult to treat, according to an article published in Nature.

30 May 2022

Drugs used for myelodysplastic syndrome could potentially activate a sleeping oncogene

Hypomethylating agents (HMA) are currently used as a first-line treatment for patients with myelodysplastic syndrome (MDS) - a group of disorders where there is insufficient production of healthy mature blood cells in the bone marrow - and increasingly in other diseases, but their mechanism of action remains unclear.

From National University of Singapore (NUS) 27 May 2022

Hospital News and Research

Study proposes a systematic engineering approach of optimizing protein-fortified food inks

Researchers create CAR T cells for cancer immunotherapy

Researchers propose a solution to delayed molecular diagnosis and therapy in childhood genetic diseases

Research shows how protein deficiency creates motor disorders in flies

Study highlights retrotransposition in CRISPR gene therapy clinical trials

Probiotics do not enhance unhealthy vaginal health, recent study shows

Study deciphers the mechanisms of bacterial host cell adhesion

Research highlights the new genetic variations and pediatric NAFLD severity

Research shows how new drugs may target genetic variations to slow Parkinson’s diseases

Scientists discover proteins that may improve CAR-T cell therapy for solid tumor model

Novel inexpensive method to detect synthetic cannabinoids and banned pesticides quickly

Researchers discover a way for detecting resistance-encoding genes in bacteria

Researchers discover effective therapy for pediatric T-acute leukemia

New computer model helps identify mutations that drive tumor growth

Researchers discover a new interferon-gamma receptor signaling pathway

Research findings provide clues on the properties that might have made A. baumannii a successful pathogen

Researchers analyze functional microglia to empower retinal organ

Damaged liver treated in perfusion machine for three days and then implanted into a cancer patient

Scientists discover a new left-handed Z-DNA technique to kill hard-to-treat tumors

Drugs used for myelodysplastic syndrome could potentially activate a sleeping oncogene

Driving Support for Pharmaceutical Testing Through Continuous Innovation

From Memory to Metaplasticity: Unraveling the Brain's Secrets

Revolutionizing Mass Spectrometry: A Deep Dive into Plasmion’s SICRIT® Technology

Latest in Genomics